Hims & Hers tumbles 15% after earnings miss as GLP-1 transition weighs on results

Shares of Hims & Hers Health (HIMS) fell sharply in premarket trading on Tuesday after the telehealth company reported weaker-than-expected first-quarter revenue and a surprise loss. The stock dropped around 15% before the opening bell after the company said changing dynamics in its GLP-1 weight-loss business had hurt margins and disrupted sales recognition during the quarter.